US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

39.29

-0.3198-0.81%

Post-market: 39.610.3198+0.81%16:10 EDT

Volume:158

Turnover:6K

Market Cap:2.95M

PE:- -

High:39.29

Open:39.61

Low:39.29

Close:39.61

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.02

T/O Rate:0.21%

Dividend:0.62

Dividend Rate:1.58%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Ultragenyx confirms FDA approval of Fayuvi

FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A

Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

Argenx Se : Jefferies Raises Target Price to $1235 from $1215

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oscar Health (OSCR) and Argenx Se (ARGX)

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/TBXU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":39.2938,"timestamp":1789761600000,"preClose":39.6136,"halted":0,"volume":158,"hourTrading":{"tag":"盘后","latestPrice":39.6136,"preClose":39.2938,"latestTime":"16:10 EDT","volume":6,"amount":236.2752,"timestamp":1789762204291,"change":0.3198,"changeRate":0.008139,"amplitude":0},"delay":0,"changeRate":-0.008072985035442393,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Market Closed","change":-0.3198,"latestTime":"09-18 16:00:00 EDT","open":39.6136,"high":39.2938,"low":39.2938,"amount":6307,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":39.6136,"sharesOutstanding":100001,"nav":39.619,"aum":2971444.91,"dividendRate":0.015824,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.6136,"preClose":39.2938,"latestTime":"16:10 EDT","volume":6,"amount":236.2752,"timestamp":1789762204291,"change":0.3198,"changeRate":0.008139,"amplitude":0},"volumeRatio":0.017816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.017816,"shares":75001,"dividePrice":0.6218,"high":39.2938,"amplitude":0,"preClose":39.6136,"low":39.2938,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":39.2938,"eps":0,"divideRate":0.015824,"volume":158,"delay":0,"ttmEps":0,"open":39.6136,"prevYearClose":31.065,"prevWeekClose":38.3601,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":38.3601,"twentyDayClose":43.3255,"sixtyDayClose":30.1137},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668973164","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973164?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:34","pubTimestamp":1789763640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.55% to $385.65 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.17% to 7,650.50 and the Dow Jones Industrial Average  falling 0.18% to 51,682.64.This was the stock's third consecutive day of gains.Amgen Inc. closed 13.73% below its 52-week high of $447.03, which the company reached on August 25th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 0.09% to $269.99, Pfizer Inc.  rose 0.07% to $27.66, and AbbVie Inc.  fell 0.02% to $263.96.Trading volume  eclipsed its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU2112291526.USD","LU0868494617.USD","PBE","LU1023059063.AUD","LU0320765992.SGD","BK4599","LU0122379950.USD","AMGN","LU1983299246.USD","IE0002141913.USD","IE0009355771.USD","LU1057294990.SGD","LU0058720904.USD","BK4585","LU1061106388.HKD","SG9999001440.SGD","BK4588","LU0109394709.USD","04332","IE00B4R5TH58.HKD","BK4533","LU0289739699.SGD","TBXU","IE00BJJMRZ35.SGD","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","LU2242652126.USD","PJP","IE00B2B36J28.USD","BBH","BK4566","BK4581","LU0889565916.HKD","LU2089984988.USD","BIB","BK4534","IBBQ","LU2468319806.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973580","title":"Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973580","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973580?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:05","pubTimestamp":1789761914,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) “announced that the U.S. Food and Drug Administration has approved its lanreotide injection, 120 mg/0.5 mL, in a ster...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","LFSC","LABU","PSCH","RSPH","BBP","TBXU","GDOC","FRTY","MRNX","TECB","SYNB","IEIH","PINK","BK4588","IDNA","MRNY","BK4007","IBB","IYH","BMED","BK4585","XLVX","MEDI","AMRX","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668282679","title":"Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111","url":"https://stock-news.laohu8.com/highlight/detail?id=2668282679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668282679?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:35","pubTimestamp":1789731320,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics (ABEO) “congratulated” Ultragenyx Pharmaceutical (RARE) on the U.S. Food and Drug Administration, FDA, approval of FAYUVI, also...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-congratulated-ultragenyx-on-u-s-fda-approval-of-ux111-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-congratulated-ultragenyx-on-u-s-fda-approval-of-ux111-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","MRNY","MRNX","BMED","BK4139","TECB","IBB","SYNB","GNMX","LFSC","XLVX","IEIH","MEDI","ABEO","BK4588","RSPH","PSCH","RARE","NVIB","FRTY","BK4585","IDNA","GDOC","BBP","IYH","TBXU","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU2468319806.SGD","SG9999001176.SGD","IDNA","LU0432979614.USD","BK4567","LU2236285917.USD","IE0002270589.USD","LU2362540622.SGD","LU1674673691.USD","IE00B894F039.SGD","BK4139","LU1035775433.USD","LU2462157665.USD","SGXZ57979304.SGD","BBH","LU1778281490.HKD","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0079474960.USD","IBBQ","LU1815336091.USD","LU2089984988.USD","LU0058720904.USD","IE0009355771.USD","IBB","LU0757428866.USD","PBE","IE00B19Z9Z06.USD","LU0289739699.SGD","IE00B19Z9P08.USD","BK4532","LU1430594728.SGD","LU2362541513.USD","LU0109394709.USD","BIB","VRTX","GNMX","SG9999001176.USD","IE00BJT1NW94.SGD","SG9999013999.USD","LU1069344957.HKD","LU1559883803.SGD","BK4585","LU0889565916.HKD","LU2237438978.USD","TBXU","VERX","BK4533","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990195","title":"Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990195?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:33","pubTimestamp":1789684401,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has provided an announcement. Vortex Energy Corp. has entered into an asset purchase agreement to acquire the M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0417517546.SGD","LU1093756325.SGD","LU1674673428.USD","GNMX","SG9999013999.USD","PBE","LU2468319806.SGD","LU2417539215.USD","TBXU","IE00B4R5TH58.HKD","IE0002270589.USD","SGXZ57979304.SGD","BBH","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","LU0256863811.USD","BK4139","LU0432979614.USD","LU2362541513.USD","VRTX","SG9999001176.USD","LU1585245621.USD","IBB","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU2456880835.USD","LU2462157665.USD","LU0823416689.USD","SG9999001176.SGD","LU1430594728.SGD","IE00B894F039.SGD","LU2236285917.USD","IBBQ","IE00BJT1NW94.SGD","LU0058720904.USD","LU2362541273.HKD","LU0079474960.USD","BK4567","BK4585","LU2324357040.USD","LU2237438978.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","BIB","BK4588","IDNA","BK4532","LU0109394709.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992198","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992198?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:34","pubTimestamp":1789677240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 2.17% to $150.89 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.07% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and Abbott Laboratories  fell 0.13% to $102.23.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1066051498.USD","LU1585245621.USD","BK4550","LU0289739699.SGD","SG9999015952.SGD","BK4139","BIB","IBBQ","LU0823416689.USD","BK4585","IE00B7SZLL34.SGD","LU0109394709.USD","LU1674673428.USD","SG9999015978.USD","LU0859254822.USD","BK4588","BK4578","LU0058720904.USD","SG9999015945.SGD","LU2357627491.SGD","LU1037948541.HKD","LU0234570918.USD","LU0965509010.AUD","LU1674673691.USD","LU0114720955.EUR","MEDI","LU1061106388.HKD","LU1023059063.AUD","LU1934455277.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1571399168.USD","BK4568","IE0002270589.USD","BK4583","IE00B3T34201.USD","LU2468319806.SGD","LU0122379950.USD","LU2087621335.USD","LU1934455194.USD","LU0965509283.SGD","LU1839511570.USD","LU2324357040.USD","LU0889565916.HKD","LU2112291526.USD","GILD","BK4532","LU0965508806.USD","LU1934455863.HKD","LU1430594728.SGD","SG9999015986.USD","TBXU","LU0861579265.USD","IBB","IE00BSNM7G36.USD","LU0320765992.SGD","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4566","TMED","LU0965509101.SGD","LU1778281490.HKD","LU2089984988.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BBH","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","MRNY","IBBQ","LU0965509101.SGD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1061106388.HKD","GNOM","LGHT","SG9999015945.SGD","LU0859254822.USD","LU0320765992.SGD","MRNA","SG9999015986.USD","LU0823416689.USD","LU2324357040.USD","WDNA","LU2089984988.USD","LU0114720955.EUR","LU0965509010.AUD","LU0882574055.USD","BBH","IDNA","BIB","BK4566","LU1934455863.HKD","LU1037948897.HKD","LU2357627491.SGD","LU0289739699.SGD","BK4568","IE00BSNM7G36.USD","LU1585245621.USD","MRNX","BK4551","IBB","LU0234570918.USD","LU0122379950.USD","LU0889565916.HKD","BK4578","LU1839511570.USD","TMED","LU1674673428.USD","BK4501","MEDI","IE00B7SZLL34.SGD","GILD","LU0861579265.USD","BK4534","LU1778281490.HKD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994030","title":"Ultragenyx confirms FDA approval of Fayuvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994030","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994030?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:55","pubTimestamp":1789674924,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) announced that the U.S. FDA granted standard full approval of Fayuvi, also known as UX111, for the treatment of pediatric patient...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","PINK","LABU","IEIH","TBXU","BMED","FRTY","IBB","PSCH","BK4139","MRNY","MEDI","IDNA","TECB","BK4585","BBP","NVIB","GNMX","IYH","XLVX","GDOC","RARE","MRNX","SYNB","BK4588","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991067","title":"FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991067","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668991067?lang=en_us&edition=fundamental","pubTime":"2026-09-18 02:35","pubTimestamp":1789670130,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration approved Fayuvi, which it calls “the first treatment for pediatric patients with mucopolysaccharidosis type I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","CNCR","GNOM","IBBQ","IBB","FBT","LABU","BK4585","LFSC","TBXU","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668397999","title":"Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668397999","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668397999?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662647,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx (ARGX) is preparing a Phase 2 study called “A Phase 2, Multicenter, Rand...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-expands-kidney-pipeline-with-new-iga-nephropathy-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-expands-kidney-pipeline-with-new-iga-nephropathy-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0390134368.USD","IE0009355771.USD","LU0823416689.USD","LU1983260115.SGD","IBB","IE0002141913.USD","IE0034235188.USD","FMED","LU0889565916.HKD","BK4505","BK4588","IE00BFTCPJ56.SGD","ARGX","LU0320765992.SGD","TBXU","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4139","IE00B4R5TH58.HKD","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993629","title":"Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993629","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993629?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662630,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predni...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","IE0009355771.USD","AMGN","IBB","LU1061106388.HKD","IE0002141913.USD","BIB","IBBQ","PJP","LU2468319806.SGD","LU0889565916.HKD","BK4599","LU0868494617.USD","LU2089984988.USD","LU0122379950.USD","LU2242652126.USD","LU1057294990.SGD","LU0058720904.USD","LU1983299246.USD","LU2112291526.USD","BK4588","BK4534","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU2242646821.SGD","LU0320765992.SGD","BK4199","TBXU","IE00BJJMRZ35.SGD","BK4566","LU0109394709.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","BK4581","IE00B2B36J28.USD","BK4139","IE00B4R5TH58.HKD","BK4585","BBH","ITP","PBE","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998797","title":"Argenx Se : Jefferies Raises Target Price to $1235 from $1215","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998797?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:13","pubTimestamp":1789654381,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU2324357040.USD","TBXU","LU0320765992.SGD","IE0002141913.USD","IBB","BK4505","BK4139","IE00B2B36J28.USD","LU0390134368.USD","BK4585","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE0034235188.USD","FMED","LU0823416689.USD","LU1983260115.SGD","IE00BJT1NW94.SGD","ARGX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","IE00BJT1NW94.SGD","BBH","LU0058720904.USD","BIB","IE00B4R5TH58.HKD","IE0002141913.USD","LU0128526141.USD","BK4530","LU2089984988.USD","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4533","BK4121","LU0390134368.USD","LU1983299246.USD","IBBQ","IBB","LU0889565916.HKD","LU1815336091.USD","LU0122379950.USD","LU0868494617.USD","LU0320765992.SGD","XLV","LU2468319806.SGD","IE0009355771.USD","PBE","HCSG","BK4534","BK4139","BK4585","LU1057294990.SGD","PJP","BK4137","AMGN","LU0757428866.USD","SG9999001440.SGD","CRL","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4599","LABU","IE00BFMHRM44.USD","BK4581","XBI","LU2112291526.USD","BK4566","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVB","GDOC","BK4588","TBXU","IBB","FRTY","BK4007","IEIH","IDNA","BK4585","PSCH","MEDI","GNMX","BBP","MRNY","XLVX","BMED","MRNX","IYH","PINK","LABU","SYNB","NVIB","RSPH","LFSC","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961345","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961345?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Atricure (ATRC) and Stryker (SYK) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","IHI","GB00B4LPDJ14.GBP","LU0029874061.USD","LU0528227936.USD","LU2506952097.USD","IE0002141913.USD","LU0868494617.USD","TBXU","LU2362541273.HKD","GB00B4QBRK32.GBP","BK4585","XLV","LABU","LU0432979614.USD","LU2362541513.USD","LU0128526141.USD","LU0690374615.EUR","LU2506951875.HKD","LU0882574055.USD","IE00BJT1NW94.SGD","BK4581","BK4566","HCSG","PBE","BBH","LU2468319806.SGD","LU2324357040.USD","LU2404859667.USD","LU0823417653.USD","LU2242652126.USD","LU2089984988.USD","BK4082","LU0690374961.EUR","LU2362540622.SGD","ATRC","BIB","BK4588","BK4599","LU0058720904.USD","LU2404859741.USD","PJP","LU1571399168.USD","IBB","AMGN","LU1061106388.HKD","SYK","LU0109394709.USD","XBI","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","IE0002270589.USD","LU0256863811.USD","LU1430594728.SGD","LU2468319806.SGD","VERX","LU2324357040.USD","MHGmain","BIB","SG9999013999.USD","COPP","IDNA","LU2236285917.USD","CPXR","IE0009355771.USD","LU1093756168.USD","UYM","LU1035775433.USD","LU0432979614.USD","ICOP","IBBQ","COPJ","LU0320765992.SGD","LU2417539215.USD","IBB","GNMX","BK4139","LU0889565916.HKD","QCmain","LU2462157665.USD","LU0823416689.USD","IE00B19Z9P08.USD","XME","IE00B894F039.SGD","LU2089984988.USD","LU0566484027.USD","LU2237438978.USD","IE00B19Z9Z06.USD","VRTX","BK4532","PBE","IE00BFTCPJ56.SGD","LU2362541513.USD","CPER","IE00B2B36J28.USD","LU1069344957.HKD","TBXU","LU1093756325.SGD","LU1778281490.HKD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","BK4007","FRTY","XLVX","TBXU","GDOC","BBP","PINK","BMED","BK4588","TECB","IYH","GNMX","NVIB","LABU","SYNB","IEIH","PSCH","LFSC","RSPH","IDNA","BAYRY","BK4585","MRNX","IBB","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668405963","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oscar Health (OSCR) and Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668405963","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668405963?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637410,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Oscar Health (OSCR) and Argenx Se (ARGX). Oscar He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-oscar-health-oscr-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-oscar-health-oscr-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","BK4551","TBXU","LU0390134368.USD","LU1983260115.SGD","IE0034235188.USD","OSCG","LU0109394709.USD","ARGX","IBB","IE00BJT1NW94.SGD","FMED","BK4588","BK4585","LU0889565916.HKD","IE00B4R5TH58.HKD","OSCX","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0823416689.USD","BK4139","BK4162","IE0002141913.USD","HEAL","IE0009355771.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","OSCR","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936994","title":"Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936994","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936994?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:35","pubTimestamp":1789594520,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced topline results from ELPIS II, its Phase 2b clinical trial evaluating its investigational stem cell therapy laromestroc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","CNCR","GDOC","MEDX","FBT","LGVN","IBB","LFSC","SYNB","BK4139","GNOM","IDNA","NVIB","TBXU","BK4588","IBBQ","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0882574055.USD","LU1674673691.USD","LU0289739699.SGD","LU0823416689.USD","IBB","LU1674673428.USD","LU1778281490.HKD","BK4532","IE00B19Z3581.USD","BK4568","BK4588","LU1023059063.AUD","BK4585","LU0234570918.USD","LU0859254822.USD","LU1066051498.USD","IE00B19Z3B42.SGD","SG9999015986.USD","TMED","IE00B3T34201.USD","IE00BKVL7J92.USD","TBXU","BIB","GILD","LU0965509101.SGD","BK4566","MEDI","LU0109394709.USD","LU0122379950.USD","LU1057294990.SGD","LU2087621335.USD","BK4578","BBH","LU0320765992.SGD","LU2357627491.SGD","LU2468319806.SGD","SG9999015952.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","BMED","IE0002270589.USD","BK4550","LU0114720955.EUR","LU1430594728.SGD","SG9999015945.SGD","IBBQ","LU0965509283.SGD","LU1585245621.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}